Dynamic Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Dynamic Capital Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-147,992	Closed	-$314K	–	471
2016 Q4	$314K	Buy	+147,992	New	+$413K	0.03%	341
2016 Q3	–	Sell	-38,056	Closed	-$119K	–	511
2016 Q2	$119K	Sell	38,056 -135,757	-78%	-$453K	0.01%	386
2016 Q1	$579K	Buy	173,813 +42,411	+32%	+$132K	0.22%	145
2015 Q4	$465K	Buy	131,402 +88,202	+204%	+$369K	0.22%	156
2015 Q3	$217K	Buy	+43,200	New	+$248K	0.06%	333
2015 Q1	–	Sell	-38,055	Closed	-$293K	–	408
2014 Q4	$293K	Sell	38,055 -223,565	-85%	-$1.77M	0.15%	177
2014 Q3	$1.95M	Buy	261,620 +214,391	+454%	+$1.99M	0.5%	57
2014 Q2	$457K	Buy	47,229 +11,704	+33%	+$104K	0.13%	262
2014 Q1	$295K	Sell	35,525 -31,805	-47%	-$273K	0.1%	332
2013 Q4	$568K	Buy	+67,330	New	+$567K	0.11%	295
2013 Q3	–	Sell	-17,739	Closed	-$137K	–	557
2013 Q2	$137K	Buy	+17,739	New	+$138K	0.04%	335

Other funds holding PDLI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Dynamic Capital Management's PDLI Position: Q1 2017 in Review

Dynamic Capital Management sold out of PDL BioPharma, Inc. (PDLI) in Q1 2017, closing a stake of 147,992 shares — an estimated $314K sold.

Dynamic Capital Management first reported a position in PDLI in Q2 2013 and held it in 11 quarters. The position peaked at $1.95M in Q3 2014. 174 funds tracked by Wall St. Rank hold PDLI as of Q1 2017.

Dynamic Capital Management reported no remaining PDL BioPharma, Inc. position as of Q1 2017 after selling out during the quarter.
Dynamic Capital Management sold 147,992 PDL BioPharma, Inc. shares in Q1 2017, an estimated $314K.
Dynamic Capital Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 11 quarters.
Dynamic Capital Management's PDL BioPharma, Inc. position peaked at $1.95M in Q3 2014.
174 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q1 2017.

Based on Dynamic Capital Management's 13F filing for Q1 2017, filed 15 May 2017.